A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.
about
Advances and challenges in malaria vaccine developmentA review of malaria vaccine clinical projects based on the WHO rainbow tableProtective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite proteinTransmission-blocking strategies: the roadmap from laboratory bench to the communityA Method for Producing Protein Nanoparticles with Applications in VaccinesAdapter reagents for protein site specific dye labelingA protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosisOligosaccharide conjugates of Bordetella pertussis and bronchiseptica induce bactericidal antibodies, an addition to pertussis vaccine.A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicleAlga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.Capsular polysaccharide vaccine for Group B Neisseria meningitidis, Escherichia coli K1, and Pasteurella haemolytica A2.Recent advances in recombinant protein-based malaria vaccines.Particle-based platforms for malaria vaccines.Expression profile of the Plasmodium falciparum intra-erythrocytic stage protein, PF3D7_1363700Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.
P2860
Q21032463-C41142A6-2916-4DF0-8822-4E759D1F5694Q21034112-27B6228D-A9A7-428E-8147-CCE2326C912CQ27310086-3D87D6A8-83C6-4C66-BB8C-194A37FFB64AQ28078982-DC844CAE-4433-4089-8B94-E8DBFF2EB256Q28550575-BED77CEB-65EF-4793-BAD1-620411CAB829Q28833748-66A7E81C-AEF8-4273-B10E-1FAC444A5AA9Q33716740-61194EC4-4BB2-4908-9709-51CEBFFB210AQ33835015-C0BAF558-D682-4903-A2F0-C488D7F64DB6Q34271517-2684C365-62D3-44C3-8E37-1F76DADE6A90Q35439931-29EEB457-4F0F-4175-BF24-17B3BA9B4988Q35518459-977FB675-114B-4E2C-9110-A5469DEDFE57Q36394182-C8EBFD4F-15E9-4CB8-A100-8094E70C6B48Q36396040-6AE483CC-7678-4CF5-9E9A-11552086EB89Q36797558-1C98E0B0-697B-405A-BDDD-8267749186D5Q39141585-A3BC359A-2C1D-4B27-AA6A-87FD28F3567C
P2860
A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugates.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@ast
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@en
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@nl
type
label
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@ast
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@en
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@nl
prefLabel
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@ast
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@en
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@nl
P2093
P2860
P50
P356
P1476
A bicomponent Plasmodium falci ...... of protein-peptide conjugates.
@en
P2093
Christopher P Mocca
Chunyan Guo
Fathy Majadly
Jerry M Keith
John B Robbins
Teh-Yung Liu
Victor Nussenzweig
Zuzana Biesova
P2860
P304
P356
10.1073/PNAS.0913374107
P407
P577
2009-12-28T00:00:00Z